Advertisement
Screener

ADMA BIOLOGICS, INC. (ADMA) Operating Income

ADMA BIOLOGICS, INC. Operating Income

ADMA BIOLOGICS, INC. (ADMA) reported Operating Income of $52.45 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-05

  • ADMA BIOLOGICS, INC. operating income (loss) for the quarter ending 2026-06-30 was $52.45M, a 22.54% increase year-over-year.
  • ADMA BIOLOGICS, INC. operating income (loss) for the quarter ending 2026-03-31 was $58.27M, a 67.07% increase year-over-year.
  • ADMA BIOLOGICS, INC. operating income (loss) for the quarter ending 2025-12-31 was $62.75M, a 63.74% increase year-over-year.
  • ADMA BIOLOGICS, INC. operating income (loss) for the quarter ending 2025-09-30 was $51.01M, a 28.69% increase year-over-year.
  • ADMA BIOLOGICS, INC. operating income (loss) for fiscal 2025 was $191.44M, a 37.75% increase from fiscal 2024.
  • ADMA BIOLOGICS, INC. operating income (loss) for fiscal 2024 was $138.98M, a 542.49% increase from fiscal 2023.
  • ADMA BIOLOGICS, INC. operating income (loss) for fiscal 2023 was $21.63M.
  • ADMA BIOLOGICS, INC. operating income (loss) for fiscal 2022 was -$39.37M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 3 month as first filedOperating Income (Loss) 6 monthOperating Income (Loss) 6 month as first filedOperating Income (Loss) 9 monthOperating Income (Loss) 9 month as first filedOperating Income (Loss) 12 monthOperating Income (Loss) 12 month as first filed
2026-06-30$52.45M
10-Q · filed 2026-08-05
$110.72M
10-Q · filed 2026-08-05
$173.47M
derived: sum of 3 quarters · filed 2026-08-05
$224.48M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$58.27M
10-Q · filed 2026-05-06
$121.03M
derived: sum of 2 quarters · filed 2026-05-06
$172.04M
derived: sum of 3 quarters · filed 2026-05-06
$214.84M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$62.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$113.76M
derived: sum of 2 quarters · filed 2026-02-25
$156.56M
derived: sum of 3 quarters · filed 2026-08-05
$191.44M
10-K · filed 2026-02-25
2025-09-30$51.01M
10-Q · filed 2025-11-05
$93.81M
derived: sum of 2 quarters · filed 2026-08-05
$128.69M
10-Q · filed 2025-11-05
$167.01M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$42.80M
10-Q · filed 2026-08-05
$77.68M
10-Q · filed 2026-08-05
$116.00M
derived: sum of 3 quarters · filed 2026-08-05
$155.64M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$34.88M
10-Q · filed 2026-05-06
$73.20M
derived: sum of 2 quarters · filed 2026-05-06
$112.84M
derived: sum of 3 quarters · filed 2026-05-06
$152.04M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$38.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$77.96M
derived: sum of 2 quarters · filed 2026-02-25
$117.16M
derived: sum of 3 quarters · filed 2026-02-25
$138.98M
10-K · filed 2026-02-25
2024-09-30$39.64M
10-Q · filed 2025-11-05
$78.84M
derived: sum of 2 quarters · filed 2025-11-05
$100.66M
10-Q · filed 2025-11-05
$114.89M
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30$39.20M
10-Q · filed 2025-08-06
$61.02M
10-Q · filed 2025-08-06
$75.25M
derived: sum of 3 quarters · filed 2026-02-25
$83.94M
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31$21.82M
10-Q · filed 2025-05-07
$36.05M
derived: sum of 2 quarters · filed 2026-02-25
$44.74M
derived: sum of 3 quarters · filed 2026-02-25
$44.27M
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31$14.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$22.92M
derived: sum of 2 quarters · filed 2026-02-25
$22.45M
derived: sum of 3 quarters · filed 2026-02-25
$21.63M
10-K · filed 2026-02-25
2023-09-30$8.69M
10-Q · filed 2024-11-07
$8.69M
10-Q · filed 2023-11-08
$8.21M
derived: sum of 2 quarters · filed 2024-11-07
$7.40M
10-Q · filed 2024-11-07
$7.40M
10-Q · filed 2023-11-08
$1.34M
derived: sum of 4 quarters · filed 2025-03-18
2023-06-30-$473.00K
10-Q · filed 2024-08-08
-$473.08K
10-Q · filed 2023-08-09
-$1.29M
10-Q · filed 2024-08-08
-$1.29M
10-Q · filed 2023-08-09
-$7.34M
derived: sum of 3 quarters · filed 2025-03-18
-$16.66M
derived: sum of 4 quarters · filed 2025-03-18
2023-03-31-$813.00K
10-Q · filed 2024-05-09
-$813.32K
10-Q · filed 2023-05-10
-$6.87M
derived: sum of 2 quarters · filed 2025-03-18
-$16.19M
derived: sum of 3 quarters · filed 2025-03-18
-$25.36M
derived: sum of 4 quarters · filed 2025-03-18
2022-12-31-$6.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
-$15.38M
derived: sum of 2 quarters · filed 2025-03-18
-$24.55M
derived: sum of 3 quarters · filed 2025-03-18
-$39.37M
10-K · filed 2025-03-18
-$39.37M
10-K · filed 2023-03-23
2022-09-30-$9.32M
10-Q · filed 2023-11-08
-$18.49M
derived: sum of 2 quarters · filed 2023-11-08
-$33.31M
10-Q · filed 2023-11-08
-$46.50M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30-$9.17M
10-Q · filed 2023-08-09
-$23.99M
10-Q · filed 2023-08-09
-$37.18M
derived: sum of 3 quarters · filed 2024-02-28
-$51.62M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31-$14.82M
10-Q · filed 2023-05-10
-$28.01M
derived: sum of 2 quarters · filed 2024-02-28
-$42.44M
derived: sum of 3 quarters · filed 2024-02-28
-$58.02M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31-$13.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
-$27.63M
derived: sum of 2 quarters · filed 2024-02-28
-$43.21M
derived: sum of 3 quarters · filed 2024-02-28
-$58.37M
10-K · filed 2024-02-28
-$58.37M
10-K · filed 2022-03-24
2021-09-30-$14.44M
10-Q · filed 2022-11-09
-$30.02M
derived: sum of 2 quarters · filed 2022-11-09
-$45.18M
10-Q · filed 2022-11-09
-$62.40M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30-$15.58M
10-Q · filed 2022-08-10
-$30.75M
10-Q · filed 2022-08-10
-$47.97M
derived: sum of 3 quarters · filed 2022-08-10
-$61.77M
derived: sum of 4 quarters · filed 2022-08-10
2021-03-31-$15.16M
10-Q · filed 2022-05-11
-$32.38M
derived: sum of 2 quarters · filed 2022-05-11
-$46.19M
derived: sum of 3 quarters · filed 2022-05-11
-$63.31M
derived: sum of 4 quarters · filed 2022-05-11
2020-12-31-$17.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24
-$31.02M
derived: sum of 2 quarters · filed 2022-03-24
-$48.15M
derived: sum of 3 quarters · filed 2022-03-24
-$64.91M
10-K · filed 2022-03-24
2020-09-30-$13.80M
10-Q · filed 2021-11-10
-$30.92M
derived: sum of 2 quarters · filed 2021-11-10
-$47.69M
10-Q · filed 2021-11-10
-$55.52M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30-$17.12M
10-Q · filed 2021-08-11
-$33.89M
10-Q · filed 2021-08-11
-$41.72M
derived: sum of 3 quarters · filed 2021-08-11
-$50.77M
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31-$16.77M
10-Q · filed 2021-05-12
-$24.60M
derived: sum of 2 quarters · filed 2021-05-12
-$33.65M
derived: sum of 3 quarters · filed 2021-05-12
-$44.99M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31-$7.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
-$16.88M
derived: sum of 2 quarters · filed 2021-03-25
-$28.22M
derived: sum of 3 quarters · filed 2021-03-25
-$41.42M
10-K · filed 2021-03-25
2019-09-30-$9.05M
10-Q · filed 2020-11-05
-$20.39M
derived: sum of 2 quarters · filed 2020-11-05
-$33.60M
10-Q · filed 2020-11-05
-$50.15M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30-$11.34M
10-Q · filed 2020-08-05
-$24.55M
10-Q · filed 2020-08-05
-$41.09M
derived: sum of 3 quarters · filed 2020-08-05
-$54.89M
derived: sum of 4 quarters · filed 2020-08-05
2019-03-31-$13.21M
10-Q · filed 2020-05-06
-$29.76M
derived: sum of 2 quarters · filed 2020-05-06
-$43.55M
derived: sum of 3 quarters · filed 2020-05-06
-$56.96M
derived: sum of 4 quarters · filed 2020-05-06
2018-12-31-$16.55M
10-K · filed 2019-03-13
-$30.34M
derived: sum of 2 quarters · filed 2019-11-06
-$43.76M
derived: sum of 3 quarters · filed 2019-11-06
-$60.29M
10-K · filed 2020-03-13
2018-09-30-$13.79M
10-Q · filed 2019-11-06
-$27.21M
derived: sum of 2 quarters · filed 2019-11-06
-$43.74M
10-Q · filed 2019-11-06
-$54.28M
derived: sum of 4 quarters · filed 2019-11-06
2018-06-30-$13.42M
10-Q · filed 2019-08-08
-$29.95M
10-Q · filed 2019-08-08
-$40.49M
derived: sum of 3 quarters · filed 2019-08-08
-$54.92M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31-$16.53M
10-Q · filed 2019-05-08
-$27.08M
derived: sum of 2 quarters · filed 2019-05-08
-$41.50M
derived: sum of 3 quarters · filed 2019-05-08
-$49.91M
derived: sum of 4 quarters · filed 2019-05-08
2017-12-31-$10.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
-$24.97M
derived: sum of 2 quarters · filed 2019-03-13
-$33.37M
derived: sum of 3 quarters · filed 2019-03-13
-$39.31M
10-K · filed 2019-03-13
2017-09-30-$14.43M
10-Q · filed 2018-11-09
-$22.83M
derived: sum of 2 quarters · filed 2018-11-09
-$28.77M
10-Q · filed 2018-11-09
-$32.71M
derived: sum of 4 quarters · filed 2018-11-09
2017-06-30-$8.40M
10-Q · filed 2018-08-10
-$14.34M
10-Q · filed 2018-08-10
-$18.28M
derived: sum of 3 quarters · filed 2018-08-10
-$22.02M
derived: sum of 4 quarters · filed 2018-08-10
2017-03-31-$5.94M
10-Q · filed 2018-05-14
-$9.88M
derived: sum of 2 quarters · filed 2018-05-14
-$13.62M
derived: sum of 3 quarters · filed 2018-05-14
-$19.11M
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31-$3.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29
-$7.68M
derived: sum of 2 quarters · filed 2018-03-29
-$13.17M
derived: sum of 3 quarters · filed 2018-03-29
-$17.33M
10-K · filed 2018-03-29
2016-09-30-$3.74M
10-Q · filed 2017-11-03
-$9.23M
derived: sum of 2 quarters · filed 2017-11-03
-$13.39M
10-Q · filed 2017-11-03
-$17.52M
derived: sum of 4 quarters · filed 2017-11-03
2016-06-30-$5.49M
10-Q · filed 2017-08-11
-$9.65M
10-Q · filed 2017-08-11
-$13.78M
derived: sum of 3 quarters · filed 2017-08-11
-$18.44M
derived: sum of 4 quarters · filed 2017-08-11
2016-03-31-$4.16M
10-Q · filed 2017-05-12
-$8.29M
derived: sum of 2 quarters · filed 2017-05-12
-$12.95M
derived: sum of 3 quarters · filed 2017-05-12
-$16.47M
derived: sum of 4 quarters · filed 2017-05-12
2015-12-31-$4.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
-$8.79M
derived: sum of 2 quarters · filed 2017-02-24
-$12.31M
derived: sum of 3 quarters · filed 2017-02-24
-$15.51M
10-K · filed 2017-02-24
2015-09-30-$4.66M
10-Q · filed 2016-11-10
-$8.18M
derived: sum of 2 quarters · filed 2016-11-10
-$11.38M
10-Q · filed 2016-11-10
-$15.09M
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30-$3.52M
10-Q · filed 2016-08-12
-$6.72M
10-Q · filed 2016-08-12
-$10.43M
derived: sum of 3 quarters · filed 2016-08-12
-$13.47M
derived: sum of 4 quarters · filed 2016-08-12
2015-03-31-$3.20M
10-Q · filed 2016-05-13
-$6.91M
derived: sum of 2 quarters · filed 2016-05-13
-$9.95M
derived: sum of 3 quarters · filed 2016-05-13
-$13.54M
derived: sum of 4 quarters · filed 2016-05-13
2014-12-31-$3.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23
-$6.75M
derived: sum of 2 quarters · filed 2016-03-23
-$10.33M
derived: sum of 3 quarters · filed 2016-03-23
-$16.02M
10-K · filed 2016-03-23
2014-09-30-$3.04M
10-Q · filed 2015-11-10
-$6.63M
derived: sum of 2 quarters · filed 2015-11-10
-$12.31M
10-Q · filed 2015-11-10
-$16.83M
derived: sum of 4 quarters · filed 2015-11-10
2014-06-30-$3.59M
10-Q · filed 2015-08-11
-$9.27M
10-Q · filed 2015-08-11
-$13.79M
derived: sum of 3 quarters · filed 2015-08-11
-$16.32M
derived: sum of 4 quarters · filed 2015-08-11
2014-03-31-$5.68M
10-Q · filed 2015-05-12
-$10.20M
derived: sum of 2 quarters · filed 2015-05-12
-$12.73M
derived: sum of 3 quarters · filed 2015-05-12
-$17.58M
derived: sum of 4 quarters · filed 2015-05-12
2013-12-31-$4.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09
-$7.05M
derived: sum of 2 quarters · filed 2015-03-09
-$11.89M
derived: sum of 3 quarters · filed 2015-03-09
-$15.04M
10-K · filed 2015-03-09
2013-09-30-$2.53M
10-Q · filed 2014-11-10
-$7.37M
derived: sum of 2 quarters · filed 2014-11-10
-$10.52M
10-Q · filed 2014-11-10
-$12.76M
derived: sum of 4 quarters · filed 2014-11-10
2013-06-30-$4.84M
10-Q · filed 2014-08-11
-$7.99M
10-Q · filed 2014-08-11
-$10.23M
derived: sum of 3 quarters · filed 2014-08-11
-$13.48M
derived: sum of 4 quarters · filed 2014-08-11
2013-03-31-$3.15M
10-Q · filed 2014-05-12
-$5.39M
derived: sum of 2 quarters · filed 2014-05-12
-$8.64M
derived: sum of 3 quarters · filed 2014-05-12
-$9.85M
derived: sum of 4 quarters · filed 2014-05-12
2012-12-31-$2.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28
-$5.49M
derived: sum of 2 quarters · filed 2014-03-28
-$6.70M
derived: sum of 3 quarters · filed 2014-03-28
-$7.91M
10-K · filed 2014-03-28
2012-09-30-$3.25M
10-Q · filed 2013-11-12
-$4.46M
derived: sum of 2 quarters · filed 2013-11-12
-$5.67M
10-Q · filed 2013-11-12
-$5.79M
derived: sum of 4 quarters · filed 2013-11-12
2012-06-30-$1.21M
10-Q · filed 2013-08-12
-$2.42M
10-Q · filed 2013-08-12
-$2.54M
derived: sum of 3 quarters · filed 2013-08-12
-$3.31M
derived: sum of 4 quarters · filed 2013-08-12
2012-03-31-$1.21M
10-Q · filed 2013-05-14
-$1.34M
derived: sum of 2 quarters · filed 2013-05-14
-$2.10M
derived: sum of 3 quarters · filed 2013-05-14
-$4.25M
derived: sum of 4 quarters · filed 2013-05-14
2011-12-31-$121.65K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-06
-$889.81K
derived: sum of 2 quarters · filed 2013-03-06
-$3.04M
derived: sum of 3 quarters · filed 2013-03-06
-$4.62M
10-K · filed 2013-03-06
2011-09-30-$768.16K
10-Q · filed 2012-11-13
-$2.92M
derived: sum of 2 quarters · filed 2012-11-13
-$4.50M
10-Q · filed 2012-11-13
2011-06-30-$2.15M
10-Q · filed 2012-08-14
-$3.73M
10-Q · filed 2012-08-14
2011-03-31-$1.59M
10-Q · filed 2012-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Greenland Mines Ltd (GRML)United States$2.362B
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43